The present invention relates methods and compositions for preventing or treating various immune diseases including graft-versus-host disease (GVHD) using populations or compositions of immunoregulatory T cells specific for an irrelevant antigen such cells being activated in vivo by a simultaneous, separate or sequential administration of said antigen.